RxDoctor Payments Data

Benjamin Smith

Optometrist · Liverpool, NYNPI 1326665944

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Alcon at 47.3% of the total. 2025 is the largest year on record at $1,333, more than ten times the $95 reported in 2020. Among optometrist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,870in general payments, 2019–2025

Across 99 payments — averaging $49.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • Bausch & Lomb Americas Inc.$424
  • Biotissue Holdings Inc.$352
  • Coopervision Inc.$247
  • Dompe US, Inc.$225
  • Johnson & Johnson Vision Care, Inc.$197
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$4,870100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,870 in reported general payments places this provider in the 90th percentile of 2,743 optometrist providers in New York.

See all optometrist providers in New York →

Medicare billing

Part B allowed, 2024
$17,561
Medicare patients
109
Services billed
993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost58$600
Timolol Maleate19$257

Paid to pharmacies, not to this prescriber.

Other optometrist in Liverpool

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →